PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27938358-1 2016 BACKGROUND: A high strength of beclomethasone/formoterol fumarate (BDP/FF) in a pressurised metered dose inhaler (pMDI), which contains extrafine BDP (200 mug/actuation) and FF (6 mug/actuation) has been developed to treat those asthmatics who are not adequately controlled on previous treatments. Formoterol Fumarate 46-65 AT-rich interaction domain 3B Homo sapiens 67-73 27938358-1 2016 BACKGROUND: A high strength of beclomethasone/formoterol fumarate (BDP/FF) in a pressurised metered dose inhaler (pMDI), which contains extrafine BDP (200 mug/actuation) and FF (6 mug/actuation) has been developed to treat those asthmatics who are not adequately controlled on previous treatments. Formoterol Fumarate 46-65 AT-rich interaction domain 3B Homo sapiens 67-70 27309985-1 2016 A fixed-dose inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and formoterol fumarate (BDP/FF) has been recently approved for use in chronic obstructive pulmonary disease (COPD). Formoterol Fumarate 129-148 AT-rich interaction domain 3B Homo sapiens 150-156 24621109-1 2014 BACKGROUND: The study evaluated the efficacy of beclomethasone dipropionate/formoterol fumarate (BDP/FF) extrafine combination versus fluticasone propionate/salmeterol (FP/S) combination in COPD patients. Formoterol Fumarate 76-95 AT-rich interaction domain 3B Homo sapiens 97-103 27340255-1 2016 The high-strength formulation of extrafine beclometasone dipropionate/formoterol fumarate (BDP/Form) 200/6 microg has been developed to step up inhaled corticosteroid treatment, without increasing the dose of the bronchodilator, in patients who are not controlled with previous therapies. Formoterol Fumarate 70-89 AT-rich interaction domain 3B Homo sapiens 91-94 32308205-6 2020 This study aimed to assess the effect of extrafine Beclometasone dipropionate/Formoterol fumarate (BDP/FF) in the control of symptoms, lung function and lung inflammation in patients with asthma. Formoterol Fumarate 78-97 AT-rich interaction domain 3B Homo sapiens 99-105